Abstract
Among 40 opioid addicts treated as outpatients with sublingual buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Buprenorphine / therapeutic use*
-
Cocaine
-
Combined Modality Therapy
-
Depressive Disorder / psychology
-
Depressive Disorder / rehabilitation*
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Methadone / therapeutic use
-
Opioid-Related Disorders / psychology
-
Opioid-Related Disorders / rehabilitation*
-
Personality Tests
-
Substance-Related Disorders / rehabilitation
Substances
-
Buprenorphine
-
Cocaine
-
Methadone